Company news

GlucoTrack, Inc. news in 2024

GlucoTrack, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Driving Innovation In Diabetes Management: Glucotrack Begins Enrollment For Human Clinical Trials For Its Implantable Continuous Blood Glucose Monitor

December 4, 2024

GlucoTrack announces start of enrollment for human clinical study of continuous blood glucose monitor

December 2, 2024

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

November 13, 2024

Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering

November 12, 2024

GlucoTrack to present at 2024 BioFuture conference

October 21, 2024

Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology

October 3, 2024

GlucoTrack announces oral & poster presentations at the 2024 diabetes technology meeting

September 30, 2024

John Ballantyne, former biotechnology executive, joins the glucotrack board of directors

September 2, 2024

GlucoTrack announces new Vice President of clinical operations

August 26, 2024

Poster Presentations, Upcoming Human Trials, Recently Secured Funding And More: Glucotrack’s Plans To Transform The Continuous Glucose Monitoring Market

August 25, 2024

Continuous Blood Glucose Monitoring Can Materially Improve The Quality Of Life For People With Diabetes – Glucotrack Wants To Make It Easier

August 20, 2024

Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

August 14, 2024

GlucoTrack announces poster presentation on continuous blood glucose monitor survey data at the association of diabetes care and education specialists (ADCES) 2024 annual conference

August 4, 2024

GlucoTrack announces new funding for development of its continuous blood glucose monitor

July 30, 2024

GlucoTrack announces the appointment of Andy Balo to board of directors

June 19, 2024

GlucoTrack reports successful completion of first reported long-term preclinical study of its epidural glucose monitoring sensor

June 12, 2024

GlucoTrack to present in the June 2024 sidoti small cap conference

June 9, 2024

GlucoTrack announces 90-day preclinical study results that demonstrate sustained accuracy of its implantable continuous blood glucose monitor

June 4, 2024

GlucoTrack’s epidural glucose monitoring sensor demonstrates successful 30-day safety & performance in long-term preclinical study

May 15, 2024

GlucoTrack announces reverse stock split

May 14, 2024

GlucoTrack announces abstracts accepted for poster presentation at 84th scientific sessions of the american diabetes association

May 1, 2024

GlucoTrack announces closing of private placement

April 21, 2024

GlucoTrack announces expansion of its continuous glucose monitoring technology to epidural glucose monitoring

April 15, 2024

GlucoTrack announces increased sensor longevity for its implantable continuous blood glucose monitor

April 1, 2024

GlucoTrack expands leadership team with new vice president of Quality

March 11, 2024

GlucoTrack selects Cirtec Medical as manufacturer for its implantable continuous blood glucose monitor

February 26, 2024

GlucoTrack announces the appointment of Luis Malavé to chair of the board of directors

February 12, 2024

GlucoTrack announces early accuracy data for its implantable continuous glucose monitor

January 1, 2024

Decks in 2024